Medications

Could targeting oxtyocin help treat opioid addiction?

A new review of published research indicates that the oxytocin system—a key player in social reward and stress regulation—is profoundly affected by opioid use. Therefore, it may be an important target for developing medications ...

Apr 05, 2017
popularity1 comments 1

Defect prompts Mylan to recall some Epipens

(HealthDay)—Mylan, the maker of the Epipen, says it is recalling "select lots" of the device used to treat dangerous allergic reactions due to a defect that might render it "difficult to activate in an emergency."

Apr 03, 2017
popularity0 comments 0